TickerFactsScreenerDevelopers

Inhibikase Therapeutics, Inc. (IKT) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2021: $-0.812022: $-4.282023: $-3.162024: $-1.162025: $-0.49$-0.49
2021EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$-0.49+57.8%
2024$-1.16+63.3%
2023$-3.16+26.2%
2022$-4.28-428.4%
2021$-0.81—